New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 11, 2019 - Pfizer announced the FDA approval of Trazimera (trastuzumab-qyyp), a biosimilar to Genentech’s Herceptin® (trastuzumab).
Download PDF
Return to publications
